THE ÓSKARE CAPITAL TEAM
Over 100 years of combined experience in venture capital, business building, science and intellectual property, and bringing medicines and products to market.
Chairman and Senior Advisors
As non-executive Chairman of ÓSKARE CAPITAL, Canadian businessman Bruce Linton provides strategic leadership and serves as head of the investment committee. Linton is a recognized leader, visionary and entrepreneur in the cannabinoid industry. In 2013 Linton co-founded Tweed, which became Canopy Growth and was the first cannabis producer to IPO on the Nasdaq in 2018 (CGC – market cap of $7 billion).
Bruce created the world’s largest diversified and integrated cannabinoid, hemp and cannabinoid derivatives company. By working closely with external Advisors, our network of investors, and with portfolio companies of ÓSKARE CAPITAL, Bruce shares his industry knowledge, network and expertise.
DR. OLIVIER BRANDICOURT
PHARMA & HEALTHCARE Executive. Former CEO of Sanofi and Bayer HealthCare AG; C-Level executive at Pfizer.
EXPERTISE: Pharmaceutical Industry, Consumer Healthcare, Strategy, Medical Affairs.
DR. MIRI HALPERIN WERNLI
Co-Founder and CEO of CRESO PHARMA. Head of Global Clinical Development, Actelion (VP Business & Scientific Affairs).
Board member MindMed.
EXPERTISE: Cannabinoids, IPOs, psychedelics, clinical trials, drug development & cannabis market.
Global Client Lead, OGILVY
Health & Wellness Practice
EXPERTISE: Corporate & Strategic Communications; Global Pharma; Consumer Health and Wellness.
Industry Analyst and Specialist in Beverages, Cannabis, and Consumer Goods, BRYAN GARNIER
EXPERTISE: Cannabis Markets, Financial Analysis, Food and Beverage Markets, Fundraising, Strategy
ZSOLT LENKEI MD, PHD
EXPERTISE: Neuroscience, Cannabinoid receptor science, basic science research methodology, mentorship to researchers and teams. PROFESSOR… read more
Alexandre OUIMET- STORRS B.ENG, M.SC
Chemical engineer (B.Eng/M.Sc) with 9 years of Venture Capital experience in Deeptech and Corporate VC
Experienced in early stage investment and incubation
Performed more than 15 investments and 40 transactions (over 100 MEUR invested)
Track record: 2.2 X and 15% IRR
Independent board member, angel investor and lecturer at Paristech
JOHN D ROGERS, MD, MPH
American trained clinical Neurologist with over 18 year track record in international healthcare, pharma and medical device sectors
Experienced Senior international Medical Affairs leader in Allergan and Galderma Nestlé Skin Health focusing on medical marketing strategies, data generation, publications & KOL engagement
Experienced CFO and Secretary General in 3 venture capital funds in France and US
Former auditor with several years of transaction experience
Experienced working with institutional investors and financial regulators
Significant fundraising experience (over 1 billion euros raised for funds)
NICOLA BROUGHTON BA, MBA, PHD, DIPLAW
20 year career in VC, life science and tech sectors with significant expertise in working with academic research groups, spinoffs, and early stage investments.
Investment Director (+ 5 years) with record in identifying and growing value in life science businesses, optimizing IP strategy, and licensing.
Experience as non-executive director in Life Science and Software companies
ZSOLT LENKEI MD, PHD
EXPERTISE: Neuroscience, Cannabinoid receptor science, basic science research methodology, mentorship to researchers and teams.
PROFESSOR AND DIRECTOR Professor, Université Pierre et Marie Curie, Centre de Psychiatrie et Neurosciences, INSERM Research Director; Co-founder, Iconeus.